What's breaking now, across thousands of outlets.
California-based drug developer Exelixis submitted new safety and efficacy data on its potential treatment of metastatic colorectal cancer (mCRC) to the FDA. The new data led to a three-month extension in the agency's review, the ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
A large study found that a history of multiple depressive episodes is tied to heightened brain activity during emotional processing.
A closer look at dementia risk reveals unexpected influences—and raises questions about how much control we really have here.
Johns Hopkins researchers developed CloudScope, a cloud-based microscope enabling continuous, remote brain imaging in freely moving mice, revealing disease progression, seizures, cellular changes and…
There’s another recall affecting sprouts, but this time it’s not the alfalfa variety . Instead, this sprout recall is linked to broccoli sprouts that have the potential to be contaminated with…
Change the incentives that reward higher prices and put real purchasing power in the hands of those who pay for care—employers, states and public programs, writes the Peterson Center on Healthcare's…
Employer and consumer organizations are urging lawmakers to address "loopholes" in the No Surprises Act.
